Evidence map›Paper›PMID 42895659›Full record

ReviewUrologie (Heidelberg, Germany)2026

[Subsequent procedures after masculinizing surgery: neourethra and prosthetics].

Melanie Poulin, Saskia Morgenstern

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Urologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Melanie PoulinKlinik für Urologie, Agaplesion Markuskrankenhaus Frankfurt, Frankfurt am Main, Deutschland, Wilhelm-Epstein-Str. 4, 60431. melanie.poulin@agaplesion.de.
Saskia MorgensternKlinik für Urologie, Agaplesion Markuskrankenhaus Frankfurt, Frankfurt am Main, Deutschland, Wilhelm-Epstein-Str. 4, 60431.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The goal of masculinizing genital surgery, which is usually performed over several planned operative stages, is to construct a genital that is both aesthetically and functionally satisfactory. It aims to create a phallus with the best possible sensitivity, a long-term stable neourethra for voiding in a standing position, and to enable penetrative sexual intercourse by means of erectile prostheses. Whether all of these steps are required depends on the individual needs of the trans man. Due to anatomical peculiarities (the absence of stable tissue types designed for the relevant function), both urethral surgery and penile prosthesis implantation differ significantly from those performed on cisgender male patients and result in higher complication rates. Since the neourethra is usually constructed from several tissue types not designed for contact with urine-such as the labia minora, vaginal mucosa, and formerly hair-bearing dermis-the main complications include urethral fistulas, strictures, and diverticulum formation, as well as hair growth within the neourethra with or without stone formation and consequent impaired urinary outflow. The most common complications of prosthesis implantation in trans men are infection, erosion, dislocation, and (premature) mechanical failure, which frequently necessitates further revisions and subsequent operations. The available evidence is predominantly based on retrospective data with small case numbers and is characterized by considerable heterogeneity regarding the definition of endpoints and the assessment of patient-reported outcomes. Despite these methodological limitations, the published studies overall show a high rate of functional satisfaction.

Indexed as

Gender-affirming surgeryNeourethral reconstructionPenile prosthesisPhalloplastyTransgender

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.